TrialMedical oncology (Northwood, London, England)2012

Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC.

A Halim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.